← Browse by Condition
Medical Condition

mash metabolic dysfunction associated steatohepatitis

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06528314 Phase 3
Recruiting

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

Enrollment
1,150 pts
Location
United States, Argen...
Sponsor
Akero Therapeutics, Inc
View Trial →